Results 31 to 40 of about 159,964 (350)

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.

open access: yesJAMA Oncology, 2020
Importance Currently, there is no established second-line systemic treatment for biliary tract cancer (BTC). Preclinical data have demonstrated that the presence of tumor-infiltrating CD8 T cells and programmed cell death 1 ligand 1-expressing tumor ...
R. Kim   +10 more
semanticscholar   +1 more source

Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015

open access: yesBMC Cancer, 2022
Biliary tract cancer (BTC) includes intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma, gallbladder cancer, and ampulla of Vater cancer (AVC). Although BTC is rare in the US, incidence is increasing and elevated in certain populations.
J. Koshiol   +4 more
semanticscholar   +1 more source

Investigation of Spatial Clustering of Biliary Tract Cancer Incidence in Osaka, Japan: Neighborhood Effect of a Printing Factory

open access: yesJournal of Epidemiology, 2016
Background: In 2013, an unusually high incidence of biliary tract cancer among current or former workers of the offset color proof printing department of a printing company in Osaka, Japan, was reported. The purpose of this study was to examine whether
Yuri Ito
doaj   +1 more source

Diet and biliary tract cancer risk in Shanghai, China. [PDF]

open access: yesPLoS ONE, 2017
Trends in biliary tract cancer incidence rates have increased in Shanghai, China. These trends have coincided with economic and developmental growth, as well as a shift in dietary patterns to a more Westernized diet.
Shakira M Nelson   +7 more
doaj   +1 more source

Updates in Biliary Tract Cancers

open access: yesCancers, 2022
Biliary tract cancers (BTCs) are a heterogeneous group of malignancies arising from the epithelium of the biliary tree [...]
Daneng Li   +3 more
openaire   +2 more sources

Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study

open access: yesScientific Reports, 2022
Biliary tract cancer (BTC) has been inconsistently identified according to its location in epidemiological and clinical studies. This study retrospectively reviewed the treatment pattern and prognosis of BTC according to tumor location using the Korea ...
M. Kang   +9 more
semanticscholar   +1 more source

Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL

open access: yesMolecular Therapy: Nucleic Acids, 2020
To systematically evaluate the whole-transcriptome sequencing data of cholangiocarcinoma (CHOL) to gain more insights into the transcriptomic landscape and molecular mechanism of this cancer, we performed whole-transcriptome sequencing based on the ...
Kai-Jian Chu   +16 more
doaj   +1 more source

Preoperative C-reactive protein as a prognostic factor for recurrence after surgical resection of biliary tract cancer [PDF]

open access: yesKorean Journal of Clinical Oncology, 2015
Purpose: C-reactive protein (CRP) has been identified to be associated with cancer development and progression. However, the role of CRP in tumor recurrence is less well defined in biliary tract cancer.
Yoon-Hwan Nam, Min-Su Park, Sang-Mok Lee
doaj   +1 more source

Global Burden, Trends, and Inequalities of Gallbladder and Biliary Tract Cancer, 1990–2021: A Decomposition and Age–Period–Cohort Analysis

open access: yesLiver international (Print)
Gallbladder and biliary tract cancer (GBTC) increasingly aggravates the global malignancy burden. This study aimed to evaluate the updated condition of GBTC temporal burden trends and inequalities from 1990 to 2021.
Sen Lei   +5 more
semanticscholar   +1 more source

Prognostic and Clinical Value of the Systemic Immune-Inflammation Index in Biliary Tract Cancer: A Meta-Analysis

open access: yesJournal of Immunological Research, 2022
Previous studies that explored the prognostic and clinical value of the systemic immune‐inflammation index (SII) in biliary tract cancer (BTC) had inconsistent results.
Xiulan Peng, Xia Wang, Li Hua, Rui Yang
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy